Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2000
03/09/2000WO2000012700A1 GENE ENCODING CDw108
03/09/2000WO2000012699A1 A transcription factor tfiid subunit, tafii105, polypeptides, dna encoding therefor and pharmaceutical compositions
03/09/2000WO2000012698A1 Human deltex-like gene zdx
03/09/2000WO2000012697A1 CLONING AND EXPRESSION OF BOVINE ESTROGEN RECEPTOR-$g(b)
03/09/2000WO2000012695A1 Novel therapeutic molecules and uses therefor
03/09/2000WO2000012692A1 Dna encoding a gababr2 polypeptide and uses thereof
03/09/2000WO2000012690A2 Laminin 5 for treatment of bone defects
03/09/2000WO2000012689A1 Polypeptides and polynucleotides from coagulase-negative staphylococci
03/09/2000WO2000012688A1 Ehrlichia canis 120-kda immunodominant antigenic protein and gene
03/09/2000WO2000012686A1 Expression systems for functional nucleic acid expression
03/09/2000WO2000012685A2 Genes associated with neurotransmitter processing
03/09/2000WO2000012683A2 Stem cells bearing an fgf receptor on the cell surface
03/09/2000WO2000012678A2 Staphylococcus aureus genes and polypeptides
03/09/2000WO2000012562A1 HUMAN ANTI-FACTOR IX/IXa ANTIBODIES
03/09/2000WO2000012560A1 Selective apoptosis of neoplastic cells by an hla-dr specific monoclonal antibody
03/09/2000WO2000012555A1 Interleukin 18-binding protein
03/09/2000WO2000012554A1 Method for marked chemokine synthesis, marked chemokine and analysis kit
03/09/2000WO2000012553A1 Cyclic prosaposin-derived peptides and uses thereof
03/09/2000WO2000012552A1 MAMMARY-SPECIFIC TRANSCRIPTION FACTOR BrEts
03/09/2000WO2000012551A1 HUMAN LATENT TRANSFORMING GROWTH FACTOR-β BINDING PROTEIN 3
03/09/2000WO2000012550A1 Novel polypeptide
03/09/2000WO2000012549A1 Protein domains in the hepatic glycogen-targetting subunit of protein phosphatase 1 and methods of making and using the same
03/09/2000WO2000012548A1 Nucleic acid and polypeptide p10 of a borna disease virus (bdv) and their use for diagnostic and immunization purposes
03/09/2000WO2000012547A2 Benzodiazepines and benzothiazepines derivatives and hbsag peptides binding to annexins, their compositions and use
03/09/2000WO2000012546A1 MAMMALIAN elk POTASSIUM CHANNEL GENES
03/09/2000WO2000012545A2 Antibodies specific for bladder nuclear matrix proteins blca-1 to blca-6
03/09/2000WO2000012544A2 Novel irap-bp polypeptide and nucleic acid molecules and uses therefor
03/09/2000WO2000012542A2 Cytotoxic lactoferrin derivatives modified by bulky or lipophilic moieties
03/09/2000WO2000012541A2 Cytotoxic peptides modified by bulky or lipophilic moieties
03/09/2000WO2000012540A1 Reversible boronate complexes of 1,2-cis-diol cyclic-peptides
03/09/2000WO2000012535A2 Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof
03/09/2000WO2000012532A1 Factor 8 homologue nucleic acids, polypeptides, methods, uses
03/09/2000WO2000012531A1 Ratc
03/09/2000WO2000012528A1 Anti-endotoxic, antimicrobial cationic peptides and methods of use therefor
03/09/2000WO2000012527A1 Antisense modulation of tradd expression
03/09/2000WO2000012525A1 Sequences characteristic of hypoxia-regulated gene transcription
03/09/2000WO2000012519A1 Phosphoepoxides, method for making same and uses
03/09/2000WO2000012506A2 Collections of compounds
03/09/2000WO2000012139A1 Hypoxia regulated genes
03/09/2000WO2000012133A1 Neisseria spp. polypeptide, nucleic acid sequence and uses thereof
03/09/2000WO2000012120A1 A pharmaceutical composition containing calcineurin b subunit
03/09/2000WO2000012119A2 PHARMACEUTICAL COMPOSITIONS COMPRISING FACTOR XIIIa
03/09/2000WO2000012118A2 Inhibiting cardiomyocyte death
03/09/2000WO2000012116A1 Method for administering insulinotropic peptides
03/09/2000WO2000012115A1 Use of composition in the treatment of schizophrenia
03/09/2000WO2000012114A1 Peptide scaffolds for transfer of molecules into eukaryotic cells
03/09/2000WO2000012113A2 Method of modulating memory effector t-cells using a cd2-binding agent, and compositions
03/09/2000WO2000012112A2 Treatment of lesions with xanthine oxidoreductase
03/09/2000WO2000012111A2 Selective treatment of endothelial somatostatin receptors
03/09/2000WO2000012109A1 α-GLUCOSIDASE INHIBITOR
03/09/2000WO2000012106A1 Gabab1aa receptor
03/09/2000WO2000012105A1 RAMP2a: RECEPTOR ACTIVITY MODIFYING PROTEIN-2a
03/09/2000WO2000012086A1 Method of mitigating the adverse effects of interleukin-2
03/09/2000WO2000012076A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
03/09/2000WO2000012075A1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use
03/09/2000WO2000012072A2 The use of fumaric acid derivatives in transplant medicine
03/09/2000WO2000012066A1 Alginate capsules for use in the treatment of brain tumour
03/09/2000WO2000012049A2 A method for the treatment of staphylococcal disease
03/09/2000WO2000012047A2 Enhancement of return to independent living status with a growth hormone secretagogue
03/09/2000WO2000012046A2 Pkdl nucleic acids, polypeptides, and diagnostic and therapeutic methods
03/09/2000WO2000012043A1 Improved stability for injection solutions
03/09/2000WO2000012028A1 Implantable system with drug-eluting cells for on-demand local drug delivery
03/09/2000WO2000012018A1 Compositions, systems, and methods for creating in situ, chemically cross-linked, mechanical barriers or covering structures
03/09/2000WO2000011969A1 Method for obtaining avian biological products
03/09/2000WO2000011965A2 Ingestible compositions comprising antibacterial agents
03/09/2000WO2000000607B1 A nucleic acid encoding a retinoblastoma binding protein (rbp-7) and polymorphic markers associated with said nucleic acid
03/09/2000WO1999065516A8 Methods and compositions for treating diseases mediated by transglutaminase activity
03/09/2000WO1999065515A3 Combination of radiotherapy and anti-angiogenic factors
03/09/2000WO1999063063A8 Cellular proteins which mediate herpesvirus entry
03/09/2000WO1999062940A9 Methods of altering cardiac cell phenotype
03/09/2000WO1999062548A9 Methods and compositions for diagnosing tauopathies
03/09/2000WO1999062537A9 Methods and agents for modulating the immune response and inflammation involving monocyte and dendritic cell membrane proteins
03/09/2000WO1999061590A9 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase src
03/09/2000WO1999060017A3 Human tumour-derived polypeptide hormone phosphatonin
03/09/2000WO1999060013A3 Il-6 antagonist peptides
03/09/2000WO1999058671A9 Human and nematode homologues of the yeast longevity assurance gene lag1
03/09/2000WO1999055873A3 Basb006 polynucleotide(s) and polypeptides from neisseria meningitis
03/09/2000WO1999053949A3 Combination of antigen pulsed apcs and interleukin 12 for tumor and viral therapy
03/09/2000WO1999051215A3 Immunosuppressive imidazole derivatives and their combination preparations with tacrolimus or cyclosporins
03/09/2000WO1999050415A3 Protease-activated receptor par4 (zchemr2)
03/09/2000WO1999043791A3 Diisopropyl fluorophosphatase and the utilization and production thereof
03/09/2000WO1999020260A3 The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function
03/09/2000WO1998052600A9 Methods of enhancing functioning of the upper gastrointestinal tract
03/09/2000DE4090565C2 Rekombinantes Herpesvirus-Pockenvirus-Vakzin A recombinant herpesvirus poxvirus vaccine
03/09/2000DE19940407A1 Stable, potent, non-toxic, broad-spectrum antitumor agent comprising dixanthate-platinum complex, especially effective against small cell lung cancer and colorectal carcinoma
03/09/2000DE19845251A1 Peptide für Pharmatargeting Peptides for drug targeting
03/09/2000DE19840758A1 Treatment of pain or depression comprises systemic administration of oxytocin
03/09/2000DE19839566A1 Verwendung von Fumarsäurederivaten in der Transplantationsmedizin Use of fumaric acid derivatives in transplantation
03/09/2000DE19839115A1 Klonierung und Expression von Rinder Estrogenrezeptor-beta Cloning and expression of bovine estrogen receptor-beta
03/09/2000DE19837230A1 Use of neurotrophin-4 as a therapeutic agent, especially for treating melanoma
03/09/2000DE19818680C1 A DNA double strand break repair protein, Nibrin, and related DNA useful for diagnosis and therapy of Nijmegen Breakage Syndrome and other diseases influenced by DNA-double-strand break repair
03/09/2000CA2633074A1 Elongase genes and uses thereof
03/09/2000CA2514899A1 Method of modulating memory effector t-cells and compositions
03/09/2000CA2435050A1 Compositions, systems, and methods for creating in situ, chemically cross-linked, mechanical barriers or covering structures
03/09/2000CA2348743A1 Laminin 5 for treatment of bone defects
03/09/2000CA2342534A1 Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof
03/09/2000CA2341810A1 Cyclic prosaposin-derived peptides and uses thereof
03/09/2000CA2341775A1 Inducible expression system
03/09/2000CA2341766A1 Mammalian elk potassium channel genes
03/09/2000CA2341761A1 Novel polypeptide
1 ... 2414 2415 2416 2417 2418 2419 2420 2421 2422 2423 2424 2425 2426 2427 2428 2429 2430 2431 2432 2433 2434 ... 3163